A Case Report on the Successful Treatment of Corticosteroid-Induced Tinea Incognito with Voriconazole

An atypical dermatophyte infection Tinea incognito results from the extended use of corticosteroids. In this condition, the typical lesion morphology is altered which creates difficulty in diagnosis; the trunk and limbs are the most affected sites. The species generally causing this disease are Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Trichophyton verrucosum, and Microsporum canis. Most frequently, the clinical presentation of Tinea incognito is that it can mimic eczema while other forms include bullous lesions, rosacea-like lichenoid and psoriasis-like wounds. Here, we present a case of a 28-year-old, male patient suffering from corticosteroid-reformed Tinea incognito which was treated with systemic voriconazole successfully. This case exhibits the effectiveness of systemic voriconazole in management of refractory Tinea incognito when the standard therapies failed to eradicate the disease. Hence, early diagnosis along with corticosteroid withdrawal and employing appropriate antifungal medication can help manage Tinea incognito.